Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Motzer, Robert J, Penkov, Konstantin, Haanen, John, Rini, Brian, Albiges, Laurence, Campbell, Matthew T, Venugopal, Balaji, Kollmannsberger, Christian, Negrier, Sylvie, Uemura, Motohide, Lee, Jae L, Vasiliev, Aleksandr, Miller, Wilson H, Gurney, Howard, Schmidinger, Manuela, Larkin, James, Atkins, Michael B, Bedke, Jens, Alekseev, Boris, Wang, Jing, Mariani, Mariangela, Robbins, Paul B, Chudnovsky, Aleksander, Fowst, Camilla, Hariharan, Subramanian, Huang, Bo, di Pietro, Alessandra, Choueiri, Toni K

Volltext

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin von Brown, Sarah D, Nativo, Paola, Smith, Jo-Ann, Stirling, David, Edwards, Paul R, Venugopal, Balaji, Flint, David J, Plumb, Jane A, Graham, Duncan, Wheate, Nial J

Volltext

Resilience of hospital and allied infrastructure during pandemic and post pandemic periods for maternal health care of pregnant women and infants in Tamil Nadu, India ‐ A counterfa... von Paramasivan, Kandaswamy, Prakash, Ashwin, Gupta, Sarthak, Phukan, Bhairav, M.R., Pavithra, Venugopal, Balaji

Volltext

VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis von Nicholson, Steve, Tovey, Holly, Elliott, Tony, Burnett, Stephanie M., Cruickshank, Clare, Bahl, Amit, Kirkbride, Peter, Mitra, Anita V., Thomson, Alastair H., Vasudev, Naveen, Venugopal, Balaji, Slade, Rachel, Tregellas, Lucy, Morgan, Bruno, Hassall, Alison, Hall, Emma, Pickering, Lisa M.

Volltext

Mesenchymal stromal cell therapy (REGENACIP ® ), a promising treatment option in chronic limb threatening ischemia - a narrative review von Desai, Sanjay, Sharma, Digvijay, Srinivas, Rajesh, Balaji, Venugopal, Thakore, Vijay, Bedi, Varinder Singh, Jindal, Ravul, Sugumaran, Amarnath, Mohanasundaram, Senthilnathan, Gogtay, Jaideep, Gupta, Pawan Kumar, Bhuiyan, Aniruddha, Atturu, Gnaneswar

Volltext

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel tr... von Ursprung, Stephan, Mossop, Helen, Gallagher, Ferdia A., Sala, Evis, Skells, Richard, Sipple, Jamal A. N., Mitchell, Thomas J., Chhabra, Anita, Fife, Kate, Matakidou, Athena, Young, Gemma, Walker, Amanda, Thomas, Martin G., Ortuzar, Mireia Crispin, Sullivan, Mark, Protheroe, Andrew, Oades, Grenville, Venugopal, Balaji, Warren, Anne Y., Stone, John, Eisen, Tim, Wason, James, Welsh, Sarah J., Stewart, Grant D.

Volltext

Retrohepatic Caval Leiomyosarcoma Antesitum Resection: A Case Report and a Review of Literature von Das, S. Aurobindo P., Paleela, Pardha S., Kuppuswamy, Madhan K., Venugopal, Balaji, Krishnan, Elankumaran

Volltext

Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer von Rulach, Robert J., McKay, Stephen, Neilson, Sam, White, Lillian, Wallace, Jan, Carruthers, Ross, Lamb, Carolynn, Cascales, Almudena, Marashi, Husam, Glen, Hilary, Venugopal, Balaji, Sadoyze, Azmat, Sidek, Norma, Russell, J. Martin, Alhasso, Abdulla, Dodds, David, Laskey, Jennifer, Jones, Robert J., MacLeod, Nicholas

Volltext

The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis von Elyan, Benjamin M P, Sullivan, Michael K, Hedley, James, De La Mata, Nicole, Webster, Angela C, Venugopal, Balaji, Jones, Rob J, Lang, Ninian N, Mark, Patrick B, Lees, Jennifer S

Volltext

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report von Meade, Angela, Frangou, Elena, Choodari-Oskooei, Babak, Larkin, James, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Gedye, Craig, Harrison, David J., Kaplan, Rick, Mulhere, Salena, Nathan, Paul, Patel, Grisma, Patel, Jay, Plant, Hannah, Ritchie, Alastair, Rush, Hannah, Shakeshaft, Clare, Stockler, Martin R., Suarez, Cristina, Thompson, Jemima, Thorogood, Nat, Venugopal, Balaji, Parmar, Mahesh K.B.

Volltext

Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience von Thangarasu, Mathisekaran, Prakash, J, Bafna, Sandeep, Aarthy, P, Govindaswamy, Thirumalai, Venugopal, Balaji, Sivaraman, Ananthakrishnan, Jain, Nitesh, Balakrishnan, Arunkumar, Raghavan, Deepak, Venkatraman, Murali, Chandranathan, M, Paul, Rajesh, Selvaraj, Nivash, Ramakrishnan, Balasubramaniam, Ragavan, Narasimhan

Volltext

Clinical Practice Recommendations for Antithrombotic Management of Peripheral Artery Disease: An Indian Perspective von Pai, Paresh, Bedi, Varinder, Kamerkar, Dhanesh, George, Robbie, Rai, Kumud, Gupta, P, Sekhar, Raghuram, Balaji, Venugopal, Parakh, Rajiv, Subramanian, S, Thakore, Vijay, Sahu, Tapish, Jindal, Ravul

Volltext

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma von Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N, Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B, Sawrycki, Piotr, Gurney, Howard, Chevreau, Christine, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Burke, John M, Doshi, Gurjyot, Topart, Delphine, Oudard, Stephane, Hammers, Hans, Kitamura, Hiroshi, Bedke, Jens, Perini, Rodolfo F, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David I, Powles, Thomas

Volltext

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, doubl... von Tomczak, Piotr, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Gross-Goupil, Marine, Burgents, Joseph E, Xu, Lei, Imai, Kentaro, Choueiri, Toni K, Venugopal, Balaji, Lin, Tzu-Ping, Symeonides, Stefan N., Sawrycki, Piotr, Haas, Naomi B., Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Hammers, Hans-Joerg, Menezes, Juliana de Janoski, Winquist, Eric W., Hamzaj, Alketa, Karaszewska, Boguslawa, Lipatov, Oleg N., McDermott, David, Kochuparambil, Samith T., Davis, Ian D., Peltola, Katriina, Sabbatini, Roberto, Shkolnik, Michail I., McCune, Steven, Yeung, Carrie, Laguerre, Brigitte, Fomin, Eugeniy A., Zakharia, Yousef, Yorio, Jeffrey T., Yanez Ruiz, Eduardo, Kimura, Go, Nishimura, Kazuo, Masumori, Naoya, Kato, Haruaki, Sala Gonzalez, Nuria, Chiu, Kun-Yuan, Atkins, Michael B., Heath, Elisabeth, Feyerabend, Susan, Numakura, Kazuyuki, Zukov, Ruslan, Maroto Rey, Pablo Jose, Chang, Chao-Hsiang, Vengalil, Salil, Waddell, Tom S., Hauke, Ralph, Jayram, Gautam, Estay, Angela, Rubiano, Juan Andres, Anai, Satoshi, Tsunemori, Hiroyuki, Sikora-Kupis, Bozena, Gunderson, Elizabeth, Koletsky, Alan, Chen, Kevin, Agrawal, Manish, Parnis, Francis, Barbosa, Fernando Maciel, Faucher, Genevieve, Iqbal, Nayyer, Hanna, Nawar, Ibanez, Carolina, Manneh, Ray, Holeckova, Petra, Ronkainen, Hanna, Abadie-Lacourtoisie, Sophie, Goebell, Peter J., Hoefner, Thomas, Schultze-Seemann, Wolfgang, Yokomizo, Akira, Matsukawa, Yoshihisa, Murakami, Yoji, Kim, Miso, Szczylik, Cezary, Humphreys, Alison C., Kumar, Birendra, Karam, Jose Antonio, Fleming, Mark, Zarba, Juan Jose, Leiva, Viviana E., Antonio Junior, Joao Neif, Rocha, Roberto Odebrecht, Muniz, David, Brust, Leandro, Graham, Jeffrey, Borchiellini, Delphine, McDermott, Ray, Miura, Yuji, Prow, Debra M., Hashemi-Sadraei, Neda, Kendall, Stephan D.

Volltext

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer von Freedland, Stephen J., de Almeida Luz, Murilo, De Giorgi, Ugo, Gleave, Martin, Gotto, Geoffrey T., Pieczonka, Christopher M., Haas, Gabriel P., Kim, Choung-Soo, Ramirez-Backhaus, Miguel, Rannikko, Antti, Tarazi, Jamal, Sridharan, Swetha, Sugg, Jennifer, Tang, Yiyun, Tutrone, Ronald F., Venugopal, Balaji, Villers, Arnauld, Woo, Henry H., Zohren, Fabian, Shore, Neal D.

Volltext

970 The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time von Elyan, Benjamin, Hedley, James, Sullivan, Michael, De La Mata, Nicole, Webster, Angela, Venugopal, Balaji, Jones, Rob, Lang, Ninian, Mark, Patrick, Lees, Jennifer

Volltext

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma von Cook, Natalie, Basu, Bristi, Smith, Donna-Michelle, Gopinathan, Aarthi, Evans, Jeffry, Steward, William P, Palmer, Daniel, Propper, David, Venugopal, Balaji, Hategan, Mirela, Anthoney, D Alan, Hampson, Lisa V, Nebozhyn, Michael, Tuveson, David, Farmer-Hall, Hayley, Turner, Helen, McLeod, Robert, Halford, Sarah, Jodrell, Duncan

Volltext

Challenges in ex-vivo resection of caval leiomyosarcoma von Krishnan, Elankumaran, Venugopal, Balaji, Ramamurthy, Anand

Volltext

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma von Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Symeonides, Stefan N., Hajek, Jaroslav, Chang, Yen-Hwa, Lee, Jae-Lyun, Sarwar, Naveed, Haas, Naomi B., Gurney, Howard, Sawrycki, Piotr, Mahave, Mauricio, Gross-Goupil, Marine, Zhang, Tian, Burke, John M., Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Oudard, Stephane, Topart, Delphine, Hammers, Hans, Kitamura, Hiroshi, McDermott, David F., Silva, Adriano, Winquist, Eric, Cornell, Jerry, Elfiky, Aymen, Burgents, Joseph E., Perini, Rodolfo F., Powles, Thomas

Volltext

Predictive value of C reactive protein (CRP) in patients with metastatic renal cell carcinoma (mRCC) treated with pembrolizumab (pembro) and axitinib (axi) von Qaisar, Aitzaz, Venugopal, Balaji, Ansel, Sonam, Jones, Robert J., Slater, Sarah, Symeonides, Stefan N., Malik, Jahangeer, Sundaramurthy, Aravindhan, Elliott, Tony, Devasar, Abeera, Stares, Mark, Randhawa, Manreet

Volltext